CM
CGTX icon

CM Management’s Cognition Therapeutics CGTX Stock Holding History

CM Management’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$304K Buy
400,000
+200,000
+100% +$233K 0.25% 68
2025
Q4 		$270K Buy
+200,000
New +$325K 0.23% 60
2025
Q3 		– Sell
-250,000
Closed -$77.5K – 69
2025
Q2 		$77.5K Sell
250,000
-150,000
-38% -$50.6K 0.07% 67
2025
Q1 		$168K Buy
400,000
+200,000
+100% +$118K 0.17% 54
2024
Q4 		$140K Sell
200,000
-50,000
-20% -$24.7K 0.13% 56
2024
Q3 		$117K Buy
250,000
+50,000
+25% +$51.5K 0.09% 64
2024
Q2 		$332K Buy
200,000
+25,000
+14% +$49.8K 0.3% 58
2024
Q1 		$319K Buy
+175,000
New +$361K 0.27% 63

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Davenport & Co Richmond, Virginia $19.6B AUM 18.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $626M AUM 67.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $35.6M AUM 76.14% 1-Year Est. Return